ArticleTargeted oncology2019

Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors.

Toshihiko Doi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.